One-pot generating subunit vaccine with high encapsulating efficiency and fast lysosome escape for potent cellular immune response.

Utilizing nanoparticles to deliver subunit vaccine is considered to be a promising strategy to improve immune response. However, currently reported systems suffered from one or more points: e.g., delicate design on molecular structures and elaborate synthesis process, low antigen and/or adjuvant encapsulation efficiency, involvement of toxic materials, and denature of bioactivity of antigen and/or adjuvant. To address these issues, here, for the first time, we developed a one-pot method to produce subunit vaccine by using hexahistidine metal assembly (HmA) to co-deliver tumor-associated antigens (GP100) and adjuvant (CpG). The generation of subunit vaccine (GP100@HmA and (GP100+CpG)@HmA) were detailly characterized by various techniques, including dynamic scatter, SEM, TEM, UV-vis, agarose gel electrophoresis, etc. HmA displayed high efficiency on encapsulating both subunits (GP100 and CpG) under mild conditions, and the generated subunit vaccine showed pH dependent release profile of loaded subunits. In the in vitro tests, such subunit vaccine behaved quick endocytosis into immune cells, fast endo/lysosomes escape, inducing maturation of antigen presentative cells and stimulating potent cellular immune response. These results suggested that HmA be a robust platform for fabricating subunit vaccine, with immense potential to immunotherapy of various diseases.

[1]  Yagang Zhang,et al.  Hexahistidine-metal Assemblies: A Facile and Effective Co-delivery System of Subunit Vaccines for Potent Humoral and Cellular Immune Responses. , 2020, Molecular pharmaceutics.

[2]  Yagang Zhang,et al.  Evaluation of His6-Metal Assemblies as a Drug Delivery Vehicle in the Treatment of Anterior Segment Disease Using a Corneal Inflammation Model. , 2020, ACS biomaterials science & engineering.

[3]  P. Horcajada,et al.  Metal-organic frameworks: A novel platform for combined advanced therapies , 2019, Coordination Chemistry Reviews.

[4]  Tinghong Zhang,et al.  Hexahistidine-metal assemblies: A promising drug delivery system. , 2019, Acta biomaterialia.

[5]  Mei X. Wu,et al.  Physical activation of innate immunity by spiky particles , 2018, Nature Nanotechnology.

[6]  H. Kaufman,et al.  Integrating oncolytic viruses in combination cancer immunotherapy , 2018, Nature Reviews Immunology.

[7]  Xuesi Chen,et al.  Highly enhanced cancer immunotherapy by combining nanovaccine with hyaluronidase. , 2018, Biomaterials.

[8]  K. Leong,et al.  Potency of a Scalable Nanoparticulate Subunit Vaccine. , 2018, Nano letters.

[9]  D. Czerwinski,et al.  Eradication of spontaneous malignancy by local immunotherapy , 2018, Science Translational Medicine.

[10]  H. Shroff,et al.  Albumin/vaccine nanocomplexes that assemble in vivo for combination cancer immunotherapy , 2017, Nature Communications.

[11]  Liping Liu,et al.  Liposomes-coated gold nanocages with antigens and adjuvants targeted delivery to dendritic cells for enhancing antitumor immune response. , 2017, Biomaterials.

[12]  Wei Chen,et al.  Nanoscale Zeolitic Imidazolate Framework-8 as Efficient Vehicles for Enhanced Delivery of CpG Oligodeoxynucleotides. , 2017, ACS applied materials & interfaces.

[13]  Soong Ho Um,et al.  Synthetic vaccine nanoparticles target to lymph node triggering enhanced innate and adaptive antitumor immunity. , 2017, Biomaterials.

[14]  R. Ahmed,et al.  Simply put: Vaccination saves lives , 2017, Proceedings of the National Academy of Sciences.

[15]  Jinchao Zhang,et al.  A simple and powerful co-delivery system based on pH-responsive metal-organic frameworks for enhanced cancer immunotherapy. , 2017, Biomaterials.

[16]  P. Walker,et al.  Enhancing Antitumor Immune Responses by Optimized Combinations of Cell-penetrating Peptide-based Vaccines and Adjuvants. , 2016, Molecular therapy : the journal of the American Society of Gene Therapy.

[17]  Xiaoli Li,et al.  Episcleral drug film for better-targeted ocular drug delivery and controlled release using multilayered poly-ε-caprolactone (PCL). , 2016, Acta biomaterialia.

[18]  K. Ishii,et al.  Vaccine adjuvants as potential cancer immunotherapeutics , 2016, International immunology.

[19]  Chao Zhang,et al.  Immune responses to vaccines delivered by encapsulation into and/or adsorption onto cationic lipid-PLGA hybrid nanoparticles. , 2016, Journal of controlled release : official journal of the Controlled Release Society.

[20]  Andreas M. Nyström,et al.  One-pot Synthesis of Metal-Organic Frameworks with Encapsulated Target Molecules and Their Applications for Controlled Drug Delivery. , 2016, Journal of the American Chemical Society.

[21]  R. Rappuoli,et al.  Self-assembling protein nanoparticles in the design of vaccines , 2015, Computational and Structural Biotechnology Journal.

[22]  Hongwei Zhao,et al.  Bacillus cereus AR156 activates PAMP-triggered immunity and induces a systemic acquired resistance through a NPR1-and SA-dependent signaling pathway. , 2016, Biochemical and biophysical research communications.

[23]  G. Ma,et al.  pH-Responsive Poly(D,L-lactic-co-glycolic acid) Nanoparticles with Rapid Antigen Release Behavior Promote Immune Response. , 2015, ACS nano.

[24]  J. R. Christensen,et al.  Polymeric nanoparticles for co-delivery of synthetic long peptide antigen and poly IC as therapeutic cancer vaccine formulation. , 2015, Journal of controlled release : official journal of the Controlled Release Society.

[25]  B. Lambrecht,et al.  Nanoporous polyelectrolyte vaccine microcarriers. A formulation platform for enhancing humoral and cellular immune responses. , 2014, Journal of controlled release : official journal of the Controlled Release Society.

[26]  M. Kumar,et al.  Nanoparticle based tailoring of adjuvant function: the role in vaccine development. , 2014, Journal of biomedical nanotechnology.

[27]  I. Melero,et al.  Therapeutic vaccines for cancer: an overview of clinical trials , 2014, Nature Reviews Clinical Oncology.

[28]  L. Chou,et al.  Optimized metal-organic-framework nanospheres for drug delivery: evaluation of small-molecule encapsulation. , 2014, ACS nano.

[29]  H. Yamaue,et al.  Antitumor immune response of dendritic cells (DCs) expressing tumor‐associated antigens derived from induced pluripotent stem cells: In comparison to bone marrow‐derived DCs , 2014, International journal of cancer.

[30]  Lingyun Cheng,et al.  Sustained release of triamcinolone acetonide from an episcleral plaque of multilayered poly-ε-caprolactone matrix. , 2014, Acta biomaterialia.

[31]  J. Hubbell,et al.  Nanoparticle conjugation of CpG enhances adjuvancy for cellular immunity and memory recall at low dose , 2013, Proceedings of the National Academy of Sciences.

[32]  J. Schenkel,et al.  Erratum: Sensing and alarm function of resident memory CD8+ T cells , 2013, Nature Immunology.

[33]  P. Stayton,et al.  pH-Responsive nanoparticle vaccines for dual-delivery of antigens and immunostimulatory oligonucleotides. , 2013, ACS nano.

[34]  Krishnendu Roy,et al.  Micro and Nanoparticle‐Based Delivery Systems for Vaccine Immunotherapy: An Immunological and Materials Perspective , 2013, Advanced healthcare materials.

[35]  Zipeng Zhao,et al.  Yolk-shell nanocrystal@ZIF-8 nanostructures for gas-phase heterogeneous catalysis with selectivity control. , 2012, Journal of the American Chemical Society.

[36]  Z. Su,et al.  The orchestration of cellular and humoral responses is facilitated by divergent intracellular antigen trafficking in nanoparticle-based therapeutic vaccine. , 2012, Pharmacological research.

[37]  Subhash Chandra Yadav,et al.  Development of peptide and protein nanotherapeutics by nanoencapsulation and nanobioconjugation , 2011, Peptides.

[38]  Wah Chiu,et al.  Interbilayer-Crosslinked Multilamellar Vesicles as Synthetic Vaccines for Potent Humoral and Cellular Immune Responses , 2011, Nature materials.

[39]  S. Geary,et al.  Nanoparticle Delivery Systems in Cancer Vaccines , 2011, Pharmaceutical Research.

[40]  Peter H Lin,et al.  Current advances in research and clinical applications of PLGA-based nanotechnology , 2009, Expert review of molecular diagnostics.

[41]  A. Hoffman,et al.  Antigen delivery with poly(propylacrylic acid) conjugation enhances MHC-1 presentation and T-cell activation. , 2009, Bioconjugate chemistry.

[42]  Hui Zhang,et al.  Immuno gold nanocages with tailored optical properties for targeted photothermal destruction of cancer cells. , 2007, Nano letters.

[43]  S. Plotkin,et al.  Vaccines: past, present and future , 2005, Nature Medicine.

[44]  I. Katayama,et al.  Interleukin 1 (IL-1α and IL-1β) induces differentiation/activation of B cell chronic lymphoid leukemia cells , 1994 .